Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).
- Citation:
- J Clin Oncol vol 32 (5s) suppl; abstr 632)
- Meeting Instance:
- ASCO 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3492
- Pharmas:
- Grants:
- Corr. Author:
- Paul Haluska
- Authors:
- Paul Haluska Albert M. Bernath Karla V. Ballman Amylou C. Dueck Hannah M. Linden Matthew P. Goetz Donald W. Northfelt Xiaonan Hou Kathleen S. Tenner Piyawan Tienchaiananda Lynn M. Flickinger Beiyun Chen Helen X. Chen Wilma L. Lingle Christine M. Pellegrino Robert W. Sponzo Monica Madden Reinholz Edith A. Perez
- Networks:
- Study
- NCCTG-N0733
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: